The Abbott Failing Heart Summit provides case-based presentations from healthcare professionals who have hands-on experience with heart failure patients and also gives a voice to those patients who are invited to tell their pre- and post-operation stories.
2024 Highlights
Failing Heart Summit Highlights
This highlight reel showcases the activities, speakers, patients, and customer engagement from the 3rd edition of the Failing Heart Summit held in Madrid, Spain from the 6th - 7th of June 2024.
Physician Presentations
Heart Failure in a nutshell
Exploring the various classifications of heart failure and examining their profound effects on national healthcare systems and society at large.
Prof. Dr. Klaus Witte, School of Medicine, University of Leeds, United Kingdom
An integrated Heart Failure device service – Can it be done, and does it work?
Clarifying the functioning of an integrated heart failure unit within an advanced heart failure center and highlighting the benefits for both patients and referring physicians alike.
Dr. Pieter Martens, Ziekenhuis Oost-Limburg, Belgium
Current guidelines (ESC/HRS) on device therapy. What’s new?
An overview of the updated device therapy guidelines from the European Society of Cardiology and the Heart Rhythm Society.
Prof. Wilfried Mullens, Ziekenhuis Oost-Limburg, Belgium
HFpEF – Treating the elephant in the room
A discussion on the general heart failure patient population and the challenges faced in treating them from a heart failure cardiologist’s perspective.
Dr. Ian Loke, Glenfield Hospital, Leicester, United Kingdom
LVAD 1.0 – Mechanism of action and indications
Focusing on the basics of how an LVAD works, highlighting the latest updates on outcomes, and detailing the approved indications for its use.
Dr. Maryam AlQaseer, King Fahad Specialist Hospital, Dammam, Saudi Arabia
Debate on how new drugs improve short-term outcomes
This is a debate focused on the challenges cardiologists face when treating patients with GDMT and determining the optimal time to refer them as heart failure progresses.
Dr. Frederik H. Verbrugge, Centre for Cardiovascular Diseases, University Hospital Brussels
Dr. Olivier C. Manintveld, Department of Cardiology, Erasmus University Medical Center
Debate
New drugs improve short-term outcomes but delay patient referral for advanced Heart Failure treatment
This is a debate focused on the challenges cardiologists face when treating patients with GDMT and determining the optimal time to refer them as heart failure progresses.
Prof. Frederik Verbrugge (Pro), University Hospital (UZ) Brussels, Belgium
Dr. Olivier Manintveld (Con), Department of Cardiology, Erasmus Medical Center, Rotterdam, Netherlands
Past Presentations
2023 Physician Presentations
When to consider a patient for advanced therapies?
Managing heart failure is challenging. Do you know how to identify those needing advanced therapies?
Dr. Olivier Manintveld
Department of Cardiology, Erasmus Medical Center,
Rotterdam, The Netherlands
Optimizing responder rate for device therapies
Don't delay CRT device implants for eligible patients.
Dr. Klaus Witte
School of Medicine, University of Leeds, England,
University Hospital Aachen, Germany
Who would be an eligible LVAD patient?
Timing is critical for heart transplants and LVAD therapies.
Dr. Owais Dar
Royal Brompton & Harefield Hospitals, London
2023 Patient Presentations
“I wish I had known about the LVAD sooner.”
- Patient testimonial*, Peter S
Join us to learn first-hand how important early treatment can be for people with heart failure.
Interviewed by Dr. Alexander Bernhardt
Department of Cardiac Surgery, University Hospital of Hamburg
Eppendorf, Germany
“COVID-19 knocked my stable heart failure situation over the edge and the LVAD brought me back on my feet.”
- Patient testimonial*, Michael G.
Earlier education can mean more options later. For LVAD recipient Michael G., it made all the difference.
Interviewed by Dr. Owais Dar
Royal Brompton & Harefield Hospitals, London
*These testimonials relate to an account of an individual's response to the treatment. This patient's account is genuine, typical and documented. However, it does not provide any indication, guide, warranty or guarantee as to the response other persons may have to the treatment. Responses to the treatment discussed can and do vary and are specific to the individual patient.
Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.
CardioMEMS™ HF System. CE marked medical device. CE0123
Legal Manufacturer: Abbott Medical, 387 Technology Circle NW, Suite 500, Atlanta, GA 30313, USA.
HeartMate 3™ Left Ventricular Assist System. CE marked medical device. CE 2797
Legal Manufacturer: Abbott Medical, 6035 Stoneridge Drive, Pleasanton CA, 94588 USA.
MAT-2313726 v2.0